Atractylodes Macrocephala Extract Liquid
Plant Origin: Rhizome of Atractylodes macrocephala Koidz.
Content Specification:
Atractylodes Polysaccharides ≥10%
Atractylenolide I ≥0.1%
CAS NO: Atractylenolide I: 473-08-5
Testing Method: HPLC
Active Ingredients: Atractylodes polysaccharides, atractylenolides (I/II/III), amino acids, volatile oils
Appearance: Brownish-yellow to dark brown clear liquid, with characteristic aromatic odor
pH: 5.0-6.5
Applications:
Health Foods: Spleen-strengthening and dampness-resolving dietary supplements, functional herbal teas
Pharmaceutical Raw Materials: Immunostimulants and gastrointestinal regulators in herbal formulations
Cosmetics: Antioxidant skincare products (e.g., serums, face masks) for improving skin dullness
Packaging:
1KG/Food-grade aluminum foil bag
25KG/Cardboard drum (lined with food-grade PE bag)
Storage: Store in a dry, cool place (≤25℃), away from direct sunlight and high temperature
Shelf Life: 24 months
Products Description
Atractylodes Macrocephala Extract Liquid is a standardized botanical extract derived from the rhizomes of Atractylodes macrocephala Koidz. via subcritical water extraction technology. Enriched with bioactive polysaccharides (≥10%) and atractylenolides (≥0.1%), this extract adheres to Chinese Pharmacopoeia and cGMP standards, serving as a key ingredient in dietary supplements, pharmaceutical formulations, and cosmetic actives.
Products Advantages
|
Atractylodes Macrocephala Extract Liquid |
Classification |
Advantage |
Specific Content |
|
Active Ingredients |
Dual-Acting Profile |
Polysaccharides ≥10% (Phenol-Sulfuric Acid Method); Atractylenolide I ≥0.1% (HPLC) |
|
|
Extraction Technology |
Low-Temp Bioactivity Preservation |
Gentle ≤60℃ extraction maintains thermolabile components like atractylenolides |
|
|
Quality Assurance |
Microbial Purity |
Total plate count ≤300CFU/g; Yeast & Mold ≤100CFU/g |
Enterprise advantage
|
Advantages of Tihealth Company |
Classification |
Advantage |
Specific Content |
|
Manufacturing Capacity |
Large-Scale Production |
1000kg/batch output with monthly capacity of 50MT |
|
|
Formulation Flexibility |
Customizable Potency |
Adjustable polysaccharides (10-30%) and atractylenolides (0.1-0.5%) |
|
|
Regulatory Compliance |
Global Certification |
FDA-registered, EU FSSAI compliant, Halal-certified |
|
Classification |
Advantage |
Specific Content |
|
Traceability System |
Blockchain-Enabled Tracking |
100% traceability from rhizome sourcing to finished product |
|
OEM Solutions |
Full-Service White Label |
Custom blending, spray-drying to powder, and private labeling |
|
Logistics Network |
Multi-Regional Distribution |
DHL/UPS express (3-7 days) and sea freight with dual customs clearance |
Products COA
Certificate of Analysis
|
Product Name: |
Atractylodes Macrocephala Extract Liquid |
Plant Origin: |
Atractylodes macrocephala Koidz. Rhizome |
|
Batch #: |
TH-20241024 |
Part Used: |
Seeds Extract |
|
Representative QTY: |
1000Kg |
Produce date: |
2024-10-24 |
|
Analysis Date: |
2024-11-1 |
Report Date: |
2024-11-2 |
|
ITEM |
SPECIFICATION |
RESULT |
|
Description: Content Pesticides Total Solids Polysaccharides Atractylenolide I |
Brownish-yellow liquid Negative 2.5% ≥10% ≥0.1% |
Complies Complies 3.17% 11.5% (Complies) 0.18% (Complies) |
|
Identification Color Reaction |
Positive Reaction |
Complies |
|
Tests: Heavy metal Pb As Hg Pesticides Appearance Color PH Odor Total Plate Yeast & Mold Salmonella E.Coli |
≤10ppm |
corresponding |
Products Function
1. Splenic Function Support & Dampness Metabolism Regulation
In traditional Chinese medicine, this extract aligns with the therapeutic principle of "strengthening the spleen and dispelling dampness." Modern mechanistic studies reveal its polysaccharide fraction (≥10%) modulates gut microbiota composition, promoting the proliferation of beneficial bacteria (e.g., Bifidobacterium and Lactobacillus) while inhibiting pathogenic strains. This gut-brain axis regulation enhances intestinal water absorption and dampness elimination, evidenced by reduced fecal water content in rat models (p<0.05). Concurrently, atractylenolides inhibit hepatic steatosis by upregulating AMPK signaling pathways, optimizing lipid metabolism and supporting splenic metabolic functions.
2. Immune Response Enhancement via Macrophage Activation
The extract's bioactive polysaccharides (MW 50-100 kDa) exhibit immunomodulatory effects by activating macrophages (RAW 264.7 cell line) through toll-like receptor 4 (TLR4)/MyD88 signaling. This leads to enhanced phagocytic activity (2.3-fold increase in phagocytic index) and upregulated secretion of pro-inflammatory cytokines (TNF-α, IL-6) in vitro. In vivo studies in BALB/c mice demonstrate a 40% reduction in bacterial load in peritoneal cavity infections, attributable to improved neutrophil chemotaxis and reactive oxygen species (ROS) production.
3. Antioxidant Activity with DPPH Radical Scavenging
The extract demonstrates potent antioxidant capacity, with a half-maximal inhibitory concentration (IC50) of ≤50 μg/mL for DPPH radical scavenging, comparable to vitamin C (IC50 ~20 μg/mL). Key contributors include phenolic acids (e.g., ferulic acid) and atractylenolides, which neutralize free radicals and reduce malondialdehyde (MDA) levels in H2O2-induced oxidative stress models. In cosmetic formulations, a 2% concentration reduces facial melanin content by 12% after 8 weeks of use (clinical trial with 50 subjects), attributing to its dual effects on ROS scavenging and tyrosinase inhibition.
4. Gastrointestinal Motility Improvement (Preclinical Evidence)
Pharmacodynamic studies in Sprague-Dawley rats show a 25% increase in gastrointestinal transit rate following oral administration of the extract (100 mg/kg), mediated by enhanced acetylcholine release and upregulated interstitial cells of Cajal (ICC) activity. Mechanistically, atractylenolide I activates voltage-gated calcium channels (VGCCs) in smooth muscle cells, promoting rhythmic contractions. These effects are comparable to metoclopramide but with fewer side effects, supporting its use in functional dyspepsia adjunct therapy.
Products Application
|
Industry |
Applications |
Regulatory Reference |
|
Nutraceuticals |
Spleen-strengthening dietary supplements |
FDA 21 CFR Part 111 |
|
Pharmaceuticals |
Immunostimulant herbal blends |
EU Traditional Herbal Medicinal Products Directive |
|
Cosmetics |
Antioxidant serums & anti-aging creams |
EU Cosmetic Regulation |
Production process
Raw Material Collection → Low-Temperature Pulverization → Ultrasonic Extraction → Filtration & Chromatography Purification → Vacuum Concentration → Quality Testing → Sterile Packaging → Global Distribution
Production OEM
The OEM services provided by Xi'an Tihealth Biotechnology Co., Ltd. have significant advantages
Custom Formulation: Adjust extract viscosity, solubility, and active ratios
Dosage Form Conversion: Spray-dried powder (water solubility ≥95%)
Regulatory Support: Documentation for FDA NDI, EU CPNP, and TGA submissions
Confidentiality: Non-disclosure agreements (NDAs) for proprietary formulas
Production Packaging

Payment Methods

Delivery methods
As a biotechnology company, Tihealth Biotechnology Company provides international cross-border e-commerce logistics services with the following characteristics:
1. International express delivery services
2. Dedicated logistics services
3. Support dual clearing service

Products FAQ
Q1: What is the shelf life under refrigeration?
A: 36 months when stored at 2-8°C in unopened original packaging.
Q2: Can this extract be used in infant products?
A: Compliant with Codex Alimentarius when diluted below 2% concentration.
Q3: What is the lead time for OEM orders?
A: 14-21 days post-formula approval and deposit receipt.
Hot Tags: atractylodes macrocephala extract liquid, China atractylodes macrocephala extract liquid manufacturers, suppliers, factory, Pepper Extract, plant extract, Liquid Sophora Flavescens, Horny Goat Weed Extract, Red Ginseng Extract, Cassia Nomame Extract
You Might Also Like
Send Inquiry










